Print this page

Targeting the Glutamatergic System for the Development of Novel Antidepressant Treatments: Pathophysiologically Informed Drug Development

Gerard Sanacora, MD, PHD
Professor, Department of Psychiatry
Yale University, School of Medicine
Director, Yale Depression Research Program

 

Click here to view the archived webcast - log in required

 

 

 

 

 

 .